Trial Profile
Quantitative comparison of F18-AV-1451 PET uptake across a range of brain regions and density of tau and amyloid pathology observed at autopsy in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2017
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 29 Aug 2017 New trial record
- 20 Jul 2017 Results (n=3) presented at the Alzheimer's Association International Conference 2017.